HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William D Figg Selected Research

Testosterone (Sustanon)

1/2017Differential Expression of OATP1B3 Mediates Unconjugated Testosterone Influx.
2/2016Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial.
12/2012Loss of OATP1B3 function causes Rotor syndrome: implications for potential use of inhibitors in cancer.
3/2012Dihydrotestosterone synthesis from adrenal precursors does not involve testosterone in castration-resistant prostate cancer.
8/2011Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study.
10/2008Kinetics of serum androgen normalization and factors associated with testosterone reserve after limited androgen deprivation therapy for nonmetastatic prostate cancer.
8/2008A polymorphism in a transporter of testosterone is a determinant of androgen independence in prostate cancer.
8/2008The genetics of castration-resistant prostate cancer: what can the germline tell us?
6/2008Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer.
3/2008Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William D Figg Research Topics

Disease

238Neoplasms (Cancer)
01/2024 - 01/2002
179Prostatic Neoplasms (Prostate Cancer)
01/2024 - 01/2002
24Neoplasm Metastasis (Metastasis)
01/2023 - 01/2002
23Disease Progression
10/2023 - 05/2005
21Breast Neoplasms (Breast Cancer)
01/2023 - 02/2003
17Hypoxia (Hypoxemia)
11/2023 - 09/2003
16Carcinoma (Carcinomatosis)
01/2024 - 10/2003
16Multiple Myeloma
11/2021 - 11/2004
14Neutropenia
01/2023 - 05/2002
10Diarrhea
01/2021 - 02/2003
9Renal Cell Carcinoma (Grawitz Tumor)
11/2023 - 07/2004
9Fatigue
01/2021 - 05/2002
7Glioma (Gliomas)
12/2023 - 06/2003
7Thrombocytopenia (Thrombopenia)
11/2021 - 05/2005
7Carcinogenesis
01/2018 - 06/2002
6Brain Neoplasms (Brain Tumor)
12/2023 - 06/2003
6Colorectal Neoplasms (Colorectal Cancer)
03/2023 - 11/2004
6Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
04/2016 - 02/2009
6Lymphoma (Lymphomas)
11/2014 - 06/2005
5Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 06/2007
5Infections
12/2021 - 07/2010
5Ovarian Neoplasms (Ovarian Cancer)
06/2021 - 08/2008
5Lung Neoplasms (Lung Cancer)
11/2020 - 04/2002
5Melanoma (Melanoma, Malignant)
11/2020 - 06/2007
5Pain (Aches)
10/2020 - 02/2003
5Hypertension (High Blood Pressure)
07/2017 - 02/2009
5T-Cell Lymphoma (Lymphoma, T Cell)
08/2013 - 02/2009
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2020 - 09/2007

Drug/Important Bio-Agent (IBA)

59AndrogensIBA
09/2023 - 05/2002
32Thalidomide (Thalomid)FDA Link
01/2018 - 02/2002
31Docetaxel (Taxotere)FDA Link
01/2021 - 01/2003
30Biomarkers (Surrogate Marker)IBA
01/2024 - 05/2002
29Androgen Receptors (Androgen Receptor)IBA
01/2021 - 01/2002
21Proteins (Proteins, Gene)FDA Link
01/2023 - 04/2002
20Hormones (Hormone)IBA
01/2022 - 05/2002
18Lenalidomide (CC 5013)FDA Link
01/2023 - 05/2002
18Histone Deacetylase InhibitorsIBA
01/2020 - 03/2002
18Prostate-Specific Antigen (Semenogelase)IBA
01/2020 - 09/2002
17Paclitaxel (Taxol)FDA LinkGeneric
06/2021 - 04/2002
15Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 01/2002
14VA 061 (VA061)IBA
12/2008 - 01/2003
13olaparibIBA
10/2023 - 06/2014
13Sorafenib (BAY 43-9006)FDA Link
11/2021 - 10/2006
13Angiogenesis InhibitorsIBA
10/2014 - 05/2002
12EnzymesIBA
10/2023 - 03/2002
12Finasteride (Propecia)FDA LinkGeneric
01/2022 - 04/2008
12Testosterone (Sustanon)FDA Link
01/2017 - 03/2006
12romidepsin (FK228)FDA Link
11/2016 - 03/2002
12Bevacizumab (Avastin)FDA Link
10/2016 - 08/2008
11DNA (Deoxyribonucleic Acid)IBA
10/2023 - 01/2002
11alvocidib (flavopiridol)IBA
01/2019 - 05/2002
10Transcription Factors (Transcription Factor)IBA
09/2017 - 09/2003
9Prednisone (Sone)FDA LinkGeneric
01/2021 - 02/2009
9entinostat (MS 275)IBA
01/2020 - 05/2004
8Immune Checkpoint InhibitorsIBA
01/2024 - 01/2015
8Antineoplastic Agents (Antineoplastics)IBA
10/2023 - 05/2002
8Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2023 - 07/2008
7enzalutamideIBA
10/2023 - 06/2015
7Interleukin-15 (Interleukin 15)IBA
11/2021 - 05/2011
7Dexamethasone (Maxidex)FDA LinkGeneric
11/2021 - 01/2017
7belinostatIBA
01/2018 - 11/2014
6Temozolomide (Temodar)FDA LinkGeneric
01/2023 - 10/2014
6SteroidsIBA
01/2022 - 12/2008
6carfilzomibIBA
11/2021 - 01/2017
6CytochromesIBA
01/2020 - 10/2005
6Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA
01/2020 - 08/2007
6PlatinumIBA
01/2020 - 07/2008
6Estrogens (Estrogen)FDA Link
01/2018 - 12/2003
6Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
06/2017 - 10/2005
6DepsipeptidesIBA
06/2011 - 03/2002
5Cisplatin (Platino)FDA LinkGeneric
01/2024 - 11/2014
5Diphosphonates (Bisphosphonates)IBA
12/2021 - 12/2002
5Tyrosine Kinase InhibitorsIBA
11/2021 - 08/2004
5abirateroneIBA
01/2021 - 12/2014
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2019 - 12/2004
5Carboplatin (JM8)FDA LinkGeneric
04/2019 - 06/2014
5carotuximabIBA
08/2017 - 09/2012
5EndoglinIBA
08/2017 - 09/2012
5Member 1 Subfamily B ATP Binding Cassette TransporterIBA
02/2011 - 07/2004
5Matrix Metalloproteinases (MMPs)IBA
06/2004 - 01/2002
4rucaparibIBA
01/2024 - 01/2021
4tremelimumabIBA
01/2024 - 01/2017
4durvalumabIBA
01/2024 - 07/2017
4Immunotoxins (Immunotoxin)IBA
01/2024 - 01/2020
4Oxygen (Dioxygen)IBA
11/2023 - 11/2005
4Monoclonal AntibodiesIBA
04/2023 - 10/2014
4CamptothecinIBA
01/2022 - 03/2020
4cabozantinibIBA
01/2022 - 01/2020
4IT-101IBA
01/2022 - 03/2020
4taxaneIBA
06/2021 - 04/2002
4pomalidomideIBA
01/2021 - 06/2007
4Immunomodulating AgentsIBA
01/2021 - 06/2007
4ProdrugsIBA
01/2021 - 12/2017
4CytokinesIBA
01/2020 - 01/2015

Therapy/Procedure

107Therapeutics
09/2023 - 04/2002
53Castration
01/2024 - 09/2007
32Drug Therapy (Chemotherapy)
01/2023 - 01/2003
11Radiotherapy
01/2023 - 02/2004
6Immunotherapy
10/2023 - 01/2015
4Precision Medicine
04/2021 - 01/2017